The peptide problem: Hype is outrunning the evidence RFK Jr. promotes peptides. Now the FDA weighs easing limits on the unproven chemicals The Food and Drug Administration will hold a meeting this summer to consider easing restrictions on more than a half dozen peptide injections, a group of unapproved therapies that have become popular BPC 157: Experimental Peptide Creates Risk for Athletes